Evaluation of home labs for patients with cancer https://t.co/XuIFAaRkKi
Time & financial toxicity are substantial burdens for patients with cancer, this study asks how can we deploy more care in the home to improve the patient experience and deliver high quality cancer care.
Waiting to Exhale: Home Blood Oxygen Monitoring Post–Hospital Discharge | JCO Clinical Cancer Informatics https://t.co/008zD54b63
In this study we ask what is the clinical value of pulse oximetry monitoring post discharge and how do we use this data to improve care?
NEW: Claudia Sheinbaum will be sworn in as president of Mexico today.
She has an opportunity to test a third option on security policy that breaks away from an unsatisfying dichotomy, writes @sarahzdaly.
https://t.co/8A1papOa4Y
THRILLED to share our work to ID & address barriers to clinical research in a regional care network at MSK
We ID 3 main barriers &:
-opened 13 trials, previously only OTA in NYC
-advocated for ⬆️ support staff
-added MDs to face sheet to permit consenting #ascoqlty24
@MSKCancerCenter@ASCO Thank you to the mentorship & collaboration of the MATCHES team: Drs. Schrag, Morris, Panageas, @inforMD@erin_bange & Drs. Doshi, Lipitz Snyderman, Polubriaginof, Kuperman, Malling, Froehlich, D'Agostino, Cheteyan!
Dr @RyanNipp with an excellent summary #ASCO24 on THREE randomized studies focused on improving the LIVED EXPERIENCE of cancer treatment and survivorship.
✅ We ARE moving the needle in advancing patient-centered care.
Dr. @BobbyDalyMD presented clinical trial data on delivering high quality #cancer care at home by integrating telemedicine into immunotherapy and integrative medicine at @ASCO.
Learn more: https://t.co/oVFnbyIi10
#ASCO24 https://t.co/0ChxrqenTS
Dr @BobbyDalyMD at #ASCO24 on impressive benefits of a virtual health #integrativeMedicine intervention during routine cancer tx. This randomized trial ⬇️ unplanned hospitalizations & hospitalization days & shows early survival benefit -not quite statistically significant (yet).
Join thoracic oncologist Dr. @michael_offin as he shares results from a pilot study on the feasibility and safety of neoadjuvant nivolumab & chemotherapy for resectable diffuse pleural #mesotheliomas at @ASCO. #ASCO24
Learn more: https://t.co/dnRrVFT0o4
📅: 6/3 at 8:24am (CT)
Wonderful presentation by @michael_offin from @MSK_DeptOfMed@MSKCancerCenter showing day from investigator initiated trial of chemo+nivo in mesothelioma, demonstrating feasibility.
Early 🐦 interview @oncodaily
sharing our work @MSKCancerOptimizing Clinical Research in a Regional Cancer Center : A Survey Based Approach.
Thank you @DianeReidyLagun & @RielyMD for your guidance & mentorship ! @MSK_DeptOfMed
Rad Onc/Neuro/Surgical Data!#ASCO24
In a post-pandemic world, at-home treatments are especially appealing to patients with cancer. Discover the successes and barriers the @MSKCancerCenter faced when testing the feasibility of at-home treatment in Oncology Issues: https://t.co/CoCEajK9So. @BobbyDalyMD